Arkansas § 20-13-408 Auto-injectable epinephrine use by an authorized entity

Arkansas Statutes

§ 20-13-408 — Auto-injectable epinephrine use by an authorized entity

Arkansas § 20-13-408

Title20

This text of Arkansas § 20-13-408 (Auto-injectable epinephrine use by an authorized entity) is published on Counsel Stack Legal Research, covering Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ark. Code Ann. § 20-13-408 (2026).

Text

(a)In order to ensure the public health and safety, an authorized entity that acquires auto-injectable epinephrine shall ensure that:

(1)An expected user:

(A)Completes appropriate knowledge and skills courses at least one (1) time every two (2) years in anaphylaxis and auto-injectable epinephrine use; and (B) Obtains a certificate under this subchapter;

(2)The auto-injectable epinephrine is maintained according to the manufacturer's operational guidelines and instructions in a locked, secure location; and (3) A person who renders emergency care or treatment to a person having an anaphylactic reaction by using auto-injectable epinephrine activates the emergency medical services system as soon as possible and immediately reports the use of auto-injectable epinephrine to the medical provi

Free access — add to your briefcase to read the full text and ask questions with AI

(a) In order to ensure the public health and safety, an authorized entity that acquires auto-injectable epinephrine shall ensure that: (1) An expected user: (A) Completes appropriate knowledge and skills courses at least one (1) time every two (2) years in anaphylaxis and auto-injectable epinephrine use; and (B) Obtains a certificate under this subchapter; (2) The auto-injectable epinephrine is maintained according to the manufacturer's operational guidelines and instructions in a locked, secure location; and (3) A person who renders emergency care or treatment to a person having an anaphylactic reaction by using auto-injectable epinephrine activates the emergency medical services system as soon as possible and immediately reports the use of auto-injectable epinephrine to the medical provider responding to the emergency. (b) An authorized entity and its expected users may: (1) Obtain a prescription in the name of the authorized entity for epinephrine auto-injectors and acquire epinephrine auto-injectors under the prescription; (2) Provide auto-injectable epinephrine for immediate self-administration to an individual who the authorized entity or expected user believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for auto-injectable epinephrine or has previously been diagnosed with an allergy; and (3) Administer auto-injectable epinephrine directly to an individual who the authorized entity or expected user believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for auto-injectable epinephrine or has been previously diagnosed with an allergy. (c) An authorized entity that possesses and makes available auto-injectable epinephrine shall: (1) (A) Submit to the Department of Health a report of each incident on the authorized entity's premises in which the authorized entity provides or administers auto-injectable epinephrine. (B) The department annually shall publish a report that summarizes and analyzes the reports submitted under this subdivision (c)(1); and (2) Notify an agent of emergency communications, 911, or vehicle dispatch center of the existence, location, and type of auto-injectable epinephrine.